← All trials
NCT06478134
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2023
- Primary completion
- Jan 10, 2024
- Completion date
- May 1, 2024
- First posted
- Jun 27, 2024
- Last posted
- Jun 27, 2024
- Enrollment
- 124
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of SevilleLead sponsor
- University of SevilleSponsor investigator
- University of SevilleOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.